This is a preprint.
Deciphering SCN2A: A comprehensive review of rodent models of Scn2a dysfunction
- PMID: 39606727
- PMCID: PMC11601800
Deciphering SCN2A: A comprehensive review of rodent models of Scn2a dysfunction
Update in
-
Deciphering SCN2A: A comprehensive review of rodent models of Scn2a dysfunction.Epilepsia. 2025 Aug 30. doi: 10.1111/epi.18615. Online ahead of print. Epilepsia. 2025. PMID: 40884529 Review.
Figures





References
-
- Adney S. K., Millichap J. J., DeKeyser J.-M., Abramova T., Thompson C. H., & George A. L. (2020). Functional and pharmacological evaluation of a novel SCN2A variant linked to early-onset epilepsy. Annals of Clinical and Translational Neurology, 7(9), 1488–1501. 10.1002/acn3.51105 - DOI - PMC - PubMed
-
- Anderson L. L., Thompson C. H., Hawkins N. A., Nath R. D., Petersohn A. A., Rajamani S., Bush W. S., Frankel W. N., Vanoye C. G., Kearney J. A., & George A. L. (2014). Antiepileptic activity of preferential inhibitors of persistent sodium current. Epilepsia, 55(8), 1274–1283. 10.1111/epi.12657 - DOI - PMC - PubMed
-
- Begemann A., Acuña M. A., Zweier M., Vincent M., Steindl K., Bachmann-Gagescu R., Hackenberg A., Abela L., Plecko B., Kroell-Seger J., Baumer A., Yamakawa K., Inoue Y., Asadollahi R., Sticht H., Zeilhofer H. U., & Rauch A. (2019). Further corroboration of distinct functional features in SCN2A variants causing intellectual disability or epileptic phenotypes. Molecular Medicine, 25(1), 6. 10.1186/s10020-019-0073-6 - DOI - PMC - PubMed
-
- Ben-Shalom R., Keeshen C. M., Berrios K. N., An J. Y., Sanders S. J., & Bender K. J. (2017). Opposing Effects on NaV1.2 Function Underlie Differences Between SCN2A Variants Observed in Individuals With Autism Spectrum Disorder or Infantile Seizures. Biological Psychiatry, 82(3), 224–232. 10.1016/j.biopsych.2017.01.009 - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources